Volume 7 Issue 5
Sep.  2016
Turn off MathJax
Article Contents
Dong Hongmeng, Dai Yang, Zhang Xinxue, et al. Meta analysis of therapeutic effects on patients with ABO-incompatibility liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(5): 370-377. doi: 10.3969/j.issn.1674-7445.2016.05.008
Citation: Dong Hongmeng, Dai Yang, Zhang Xinxue, et al. Meta analysis of therapeutic effects on patients with ABO-incompatibility liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(5): 370-377. doi: 10.3969/j.issn.1674-7445.2016.05.008

Meta analysis of therapeutic effects on patients with ABO-incompatibility liver transplantation

doi: 10.3969/j.issn.1674-7445.2016.05.008
More Information
  •   Objective  To systematic evaluation the therapeutic effects on patients with ABO-incompatibility liver transplantation (ILT), and compare the curative effect with ABO-compatible liver transplantation (CLT).  Methods  The literatures of comparison in clinical efficacy between ILT and CLT were collected at home and abroad by computer search in PubMed database, Embase database, Cochrane database, Medline database, Web of science database, CNKI, Wanfang database, VIP database, et al, and the quality of literatures were accessed. Meta analysis was carried out by fixed effect model and random effect model with RevMan5.3 software.  Results  A total of 18 papers were included. The results of Meta analysis showed that there was no significant difference in the survival rates of recipient between ILT group and CLT group at 1, 3 and 5 years after operation (all P > 0.05). Compared with CLT group, the survival rates of grafts were significantly decreased in ILT group at 1, 3 and 5 years after operation, and the difference was statistically significant (all P < 0.05). The incidences of postoperative biliary complication and acute rejection in ILT group were significantly higher than those in CLT group, the difference was statistically significant (both P < 0.05).  Conclusions  Compared with CLT, the curative effect of ILT is weaker but still can be used as a new choice for critical condition of the recipient or waiting for the donor liver for a long time.

     

  • loading
  • [1]
    Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers[J]. Lancet, 1990, 336(8714):519-523. doi: 10.1016/0140-6736(90)92082-S
    [2]
    Reding R, Veyckemans F, de Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications[J]. Surg Gynecol Obstet, 1992, 174(1):59-64. http://dial.uclouvain.be/pr/boreal/object/boreal:13671?site_name=UCL
    [3]
    Bjoro K, Ericzon B G, Kirkegaard P, et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation[J]. Transplantation, 2003, 75(3):347-353. doi: 10.1097/01.TP.0000044359.72379.E5
    [4]
    Soejima Y, Muto J, Matono R, et al. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases[J]. Clin Transplant, 2013, 27(2):227-231. doi: 10.1111/ctr.12060
    [5]
    Lee J, Lee JG, Lee JJ, et al. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution[J]. Transplant Proc, 2015, 47(3):723-726. doi: 10.1016/j.transproceed.2015.02.004
    [6]
    Song GW, Lee SG, Hwang S, et al. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era[J]. J Hepatol, 2014, 61(3):575-582. doi: 10.1016/j.jhep.2014.04.039
    [7]
    Sanchez-Urdazpal L, Batts KP, Gores GJ, et al. Increased bile duct complications in liver transplantation across the ABO barrier[J]. Ann Surg, 1993, 218(2):152-158. doi: 10.1097/00000658-199308000-00006
    [8]
    Cacciarelli TV, So SK, Lim J, et al. A reassessment of ABO incompatibility in pediatric liver transplantation[J]. Transplantation, 1995, 60(7):757-760. doi: 10.1097/00007890-199510150-00024
    [9]
    Varela-Fascinetto G, Treacy SJ, Lillehei CW, et al. Long-term results in pediatric ABO-incompatible liver transplantation[J]. Transplant Proc, 1999, 31(1/2):467-468. https://www.researchgate.net/profile/Gustavo_Varela-Fascinetto/publication/13208254_Long-term_results_in_pediatric_ABO-incompatible_liver/links/555cdd2d08ae6f4dcc8bd05e.pdf?inViewer=0&pdfJsDownload=0&origin=publication_detail
    [10]
    Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation[J]. Transplantation, 2004, 77(3):403-411. doi: 10.1097/01.TP.0000110295.88926.5C
    [11]
    Heffron T, Welch D, Pillen T, et al. Successful ABO-incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis[J]. Liver Transpl, 2006, 12(6):972-978. doi: 10.1002/(ISSN)1527-6473
    [12]
    Ueda M, Oike F, Ogura Y, et al. Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center[J]. Liver Transpl, 2006, 12(9):1326-1336. doi: 10.1002/(ISSN)1527-6473
    [13]
    杨扬, 许赤, 陈颖华, 等.血型不合肝移植治疗肝功能衰竭[J].中华医学杂志, 2007, 87(40):2833-2836. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHYX200740007.htm

    Yang Y, Xu C, Chen YH, et al. Treatment of ABO-incompatible liver transplantation on liver failure[J]. Natl Med J China, 2007, 87(40):2833-2836. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHYX200740007.htm
    [14]
    Toso C, Al-Qahtani M, Alsaif FA, et al. ABO-incompatible liver transplantation for critically ill adult patients[J]. Transpl Int, 2007, 20(8):675-681. doi: 10.1111/tri.2007.20.issue-8
    [15]
    Stewart ZA, Locke JE, Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the united states: a national registry analysis[J]. Liver Transpl, 2009, 15(8):883-893. doi: 10.1002/lt.v15:8
    [16]
    沈中阳, 邓永林, 郑虹, 等. ABO血型不合肝移植治疗急危重症肝病患者的临床疗效分析[J].中华危重病急救医学, 2014, 26(8):529-533. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL200903008.htm

    Shen ZY, Deng YL, Zheng H, et al. Analysis of the curative effect of ABO-incompatible liver transplantation in the treatment in patients with acute severe liver disease[J]. Chin Crit Care Med, 2014, 26(8):529-533. http://www.cnki.com.cn/Article/CJFDTOTAL-ZPWL200903008.htm
    [17]
    Shen T, Lin BY, Jia JJ, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(4):395-401. doi: 10.1016/S1499-3872(14)60268-X
    [18]
    Thorsen T, Dahlgren US, Aandahl EM, et al. Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications[J]. Transpl Int, 2015, 28(7):800-812. doi: 10.1111/tri.12552
    [19]
    Lee CF, Cheng CH, Wang YC, et al. Adult living donor liver transplantation across ABO-incompatibility[J]. Medicine, 2015, 94(42):e1796. doi: 10.1097/MD.0000000000001796
    [20]
    Iwamoto H, Hama K, Nakamura Y, et al. Biliary complications after 52 adult living donor liver transplantations: a single-center experience[J]. Transplant Proc, 2008, 40(8):2539-2541. doi: 10.1016/j.transproceed.2008.07.042
    [21]
    阎冰, 李捷, 郭文治, 等. ABO血型不合肝移植术后急性抗体介导的排斥反应研究进展[J/CD].中华肝脏外科手术学电子杂志, 2014, 3(2):124-126. http://www.doc88.com/p-9149552444571.html

    Yan B, Li J, Guo WZ, et al. Research progress on acute antibody-mediated rejection after ABO-incompatible liver transplantation[J/CD]. Chin J Hepatic Surg(Electr Edit), 2014, 3(2):124-126. http://www.doc88.com/p-9149552444571.html
    [22]
    鞠卫强, 周健, 何晓顺, 等.供受者ABO血型不符的成人肝脏移植疗效评价[J].中华医学杂志, 2011, 91(36):2558-2560. http://www.cqvip.com/qk/93850x/201136/39502433.html

    Ju WQ, Zhou J, He XS, et al. Clinical efficacies of ABO-incompatible adult liver transplantation[J]. Natl Med J China, 2011, 91(36):2558-2560. http://www.cqvip.com/qk/93850x/201136/39502433.html
    [23]
    Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study[J]. Am J Transplant, 2014, 14(1):102-114. doi: 10.1111/ajt.12520
    [24]
    Kim JM, Kwon CH, Joh JW, et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor[J]. J Hepatol, 2013, 59(6):1215-1222. doi: 10.1016/j.jhep.2013.07.035
    [25]
    Raut V, Mori A, Kaido T, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab[J]. Transplantation, 2012, 93(1):99-105. doi: 10.1097/TP.0b013e318239e8e4
    [26]
    Nemes B, Gámán G, Doros A. Biliary complications after liver transplantation[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(4):447-466. doi: 10.1586/17474124.2015.967761
    [27]
    Lee SD, Kim SH, Kong SY, et al. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy[J]. HPB, 2014, 16(9):807-813. doi: 10.1111/hpb.12215
    [28]
    Sintra SN, Tomé L, Cipriano MA, et al. Long-term outcome of the first 150 liver transplant recipients: a single-center experience[J]. Transplant Proc, 2013, 45(3):1119-1121. doi: 10.1016/j.transproceed.2013.02.101
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Article Metrics

    Article views (83) PDF downloads(5) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return